Results · Apr-Jun 2026
Pfizer Q1 FY27 results
Sales grew 8% to ₹653 crore from ₹603 crore in Apr-Jun 2025.
Operating profit grew 18% to ₹248 crore, an operating margin of 37.9% (up 3.1 points from a year ago).
Net profit grew 7% to ₹204 crore from ₹192 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales +4%, net profit +2%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 653.2 | 603.1 | +8% |
| Operating profit (EBITDA) | 247.6 | 210.0 | +18% |
| Operating margin | 37.9% | 34.8% | +3.1 pts |
| Net profit | 204.5 | 191.8 | +7% |
Standalone figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
From the company's results filed on BSE (Standalone). Business numbers only. Education & analysis, not investment advice or a recommendation.